Japan Pneumococcal Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (MSD).

    This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Pneumococcal Vaccine market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Pneumococcal Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Pneumococcal Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • CDIBP

    • GSK

    • Sanofipasteur

    • Pfizer

    • MSD

    By Type:

    • PPSV 23

    • PCV 7/13

    • PCV 10

    By End-User:

    • Infants

    • Children (2-10)

    • Person (10-64)

    • The old (=65)

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pneumococcal Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Pneumococcal Vaccine Market Size and Growth Rate of PPSV 23 from 2014 to 2026

      • 1.3.2 Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

      • 1.3.3 Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Infants

      • 1.4.2 Market Size and Growth Rate of Children (2-10)

      • 1.4.3 Market Size and Growth Rate of Person (10-64)

      • 1.4.4 Market Size and Growth Rate of The old (=65)

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pneumococcal Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pneumococcal Vaccine by Major Types

      • 3.4.1 Japan Pneumococcal Vaccine Market Size and Growth Rate of PPSV 23 from 2014 to 2026

      • 3.4.2 Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

      • 3.4.3 Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 10 from 2014 to 2026

    4 Segmentation of Pneumococcal Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pneumococcal Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pneumococcal Vaccine in Infants

      • 4.4.2 Market Size and Growth Rate of Pneumococcal Vaccine in Children (2-10)

      • 4.4.3 Market Size and Growth Rate of Pneumococcal Vaccine in Person (10-64)

      • 4.4.4 Market Size and Growth Rate of Pneumococcal Vaccine in The old (=65)

    5 Market Analysis by Regions

    • 5.1 Japan Pneumococcal Vaccine Production Analysis by Regions

    • 5.2 Japan Pneumococcal Vaccine Consumption Analysis by Regions

    6 Hokkaido Pneumococcal Vaccine Landscape Analysis

    • 6.1 Hokkaido Pneumococcal Vaccine Landscape Analysis by Major Types

    • 6.2 Hokkaido Pneumococcal Vaccine Landscape Analysis by Major End-Users

    7 Tohoku Pneumococcal Vaccine Landscape Analysis

    • 7.1 Tohoku Pneumococcal Vaccine Landscape Analysis by Major Types

    • 7.2 Tohoku Pneumococcal Vaccine Landscape Analysis by Major End-Users

    8 Kanto Pneumococcal Vaccine Landscape Analysis

    • 8.1 Kanto Pneumococcal Vaccine Landscape Analysis by Major Types

    • 8.2 Kanto Pneumococcal Vaccine Landscape Analysis by Major End-Users

    9 Chubu Pneumococcal Vaccine Landscape Analysis

    • 9.1 Chubu Pneumococcal Vaccine Landscape Analysis by Major Types

    • 9.2 Chubu Pneumococcal Vaccine Landscape Analysis by Major End-Users

    10 Kinki Pneumococcal Vaccine Landscape Analysis

    • 10.1 Kinki Pneumococcal Vaccine Landscape Analysis by Major Types

    • 10.2 Kinki Pneumococcal Vaccine Landscape Analysis by Major End-Users

    11 Chugoku Pneumococcal Vaccine Landscape Analysis

    • 11.1 Chugoku Pneumococcal Vaccine Landscape Analysis by Major Types

    • 11.2 Chugoku Pneumococcal Vaccine Landscape Analysis by Major End-Users

    12 Shikoku Pneumococcal Vaccine Landscape Analysis

    • 12.1 Shikoku Pneumococcal Vaccine Landscape Analysis by Major Types

    • 12.2 Shikoku Pneumococcal Vaccine Landscape Analysis by Major End-Users

    13 Kyushu Pneumococcal Vaccine Landscape Analysis

    • 13.1 Kyushu Pneumococcal Vaccine Landscape Analysis by Major Types

    • 13.2 Kyushu Pneumococcal Vaccine Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 CDIBP

      • 14.1.1 CDIBP Company Profile and Recent Development

      • 14.1.2 CDIBP Market Performance

      • 14.1.3 CDIBP Product and Service Introduction

    • 14.2 GSK

      • 14.2.1 GSK Company Profile and Recent Development

      • 14.2.2 GSK Market Performance

      • 14.2.3 GSK Product and Service Introduction

    • 14.3 Sanofipasteur

      • 14.3.1 Sanofipasteur Company Profile and Recent Development

      • 14.3.2 Sanofipasteur Market Performance

      • 14.3.3 Sanofipasteur Product and Service Introduction

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Profile and Recent Development

      • 14.4.2 Pfizer Market Performance

      • 14.4.3 Pfizer Product and Service Introduction

    • 14.5 MSD

      • 14.5.1 MSD Company Profile and Recent Development

      • 14.5.2 MSD Market Performance

      • 14.5.3 MSD Product and Service Introduction

     

    The List of Tables and Figures (Totals 109 Figures and 169 Tables)

    • Figure Japan Pneumococcal Vaccine Market Size and Growth Rate of PPSV 23 from 2014 to 2026

    • Figure Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

    • Figure Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Infants

    • Figure Market Size and Growth Rate of Children (2-10)

    • Figure Market Size and Growth Rate of Person (10-64)

    • Figure Market Size and Growth Rate of The old (=65)

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Pneumococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pneumococcal Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pneumococcal Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pneumococcal Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccine by Different Types from 2014 to 2026

    • Figure Japan Pneumococcal Vaccine Market Size and Growth Rate of PPSV 23 from 2014 to 2026

    • Figure Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

    • Figure Japan Pneumococcal Vaccine Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pneumococcal Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infants

    • Figure Market Size and Growth Rate of Children (2-10)

    • Figure Market Size and Growth Rate of Person (10-64)

    • Figure Market Size and Growth Rate of The old (=65)

    • Table Japan Pneumococcal Vaccine Production by Regions

    • Table Japan Pneumococcal Vaccine Production Share by Regions

    • Figure Japan Pneumococcal Vaccine Production Share by Regions in 2014

    • Figure Japan Pneumococcal Vaccine Production Share by Regions in 2018

    • Figure Japan Pneumococcal Vaccine Production Share by Regions in 2026

    • Table Japan Pneumococcal Vaccine Consumption by Regions

    • Table Japan Pneumococcal Vaccine Consumption Share by Regions

    • Figure Japan Pneumococcal Vaccine Consumption Share by Regions in 2014

    • Figure Japan Pneumococcal Vaccine Consumption Share by Regions in 2018

    • Figure Japan Pneumococcal Vaccine Consumption Share by Regions in 2026

    • Table Hokkaido Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Hokkaido Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Hokkaido Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Hokkaido Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Hokkaido Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Hokkaido Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Hokkaido Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Tohoku Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Tohoku Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Tohoku Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Tohoku Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Tohoku Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Tohoku Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Tohoku Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Tohoku Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Kanto Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Kanto Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kanto Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Kanto Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Kanto Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Kanto Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kanto Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Kanto Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Kanto Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Chubu Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Chubu Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chubu Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Chubu Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Chubu Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Chubu Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chubu Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Chubu Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Chubu Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Kinki Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Kinki Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kinki Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Kinki Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Kinki Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Kinki Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kinki Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Kinki Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Kinki Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Chugoku Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Chugoku Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Chugoku Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Chugoku Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Chugoku Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chugoku Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Chugoku Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Chugoku Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Shikoku Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Shikoku Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Shikoku Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Shikoku Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Shikoku Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Shikoku Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Shikoku Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Shikoku Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Kyushu Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Kyushu Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Pneumococcal Vaccine Consumption Share by Types in 2014

    • Figure Kyushu Pneumococcal Vaccine Consumption Share by Types in 2018

    • Figure Kyushu Pneumococcal Vaccine Consumption Share by Types in 2026

    • Table Kyushu Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kyushu Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Pneumococcal Vaccine Consumption Share by End-Users in 2014

    • Figure Kyushu Pneumococcal Vaccine Consumption Share by End-Users in 2018

    • Figure Kyushu Pneumococcal Vaccine Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of CDIBP

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CDIBP

    • Figure Sales and Growth Rate Analysis of CDIBP

    • Figure Revenue and Market Share Analysis of CDIBP

    • Table Product and Service Introduction of CDIBP

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Sanofipasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofipasteur

    • Figure Sales and Growth Rate Analysis of Sanofipasteur

    • Figure Revenue and Market Share Analysis of Sanofipasteur

    • Table Product and Service Introduction of Sanofipasteur

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of MSD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MSD

    • Figure Sales and Growth Rate Analysis of MSD

    • Figure Revenue and Market Share Analysis of MSD

    • Table Product and Service Introduction of MSD

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.